Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Influenza A H1N1 vaccine - Bharat Biotech

Drug Profile

Influenza A H1N1 vaccine - Bharat Biotech

Alternative Names: Cell cultured inactivated BBIL H1N1 vaccine; HN-VAC; HNVAC; Influenza A/H1N1 adjuvant vaccine (HN-VAC) - Bharat Biotech

Latest Information Update: 14 Jul 2011

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bharat Biotech
  • Class Influenza A virus H1N1 vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Influenza A virus H1N1 subtype

Most Recent Events

  • 18 Oct 2010 Launched for Influenza-A virus H1N1 subtype in India (IM); first global launch
  • 21 Jul 2010 Bharat Biotech completes enrolment in its phase II/III trial for Influenza A-virus H1N1 subtype (in volunteers) in India
  • 19 Jan 2010 Phase-I clinical trials in Influenza-A virus H1N1 subtype (prevention) in India (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top